Related Experiment Videos
Cutaneous leishmaniasis: treatment with ketoconazole
Cutis
|September 1, 1983
Summary
Ketoconazole effectively treated a 17-year-old boy's cutaneous leishmaniasis. The broad-spectrum antimycotic drug showed excellent clinical and protozoological improvement in this case study.
Area of Science:
- Dermatology
- Infectious Diseases
- Pharmacology
Background:
- Cutaneous leishmaniasis is a parasitic skin infection.
- Treatment options for leishmaniasis can be limited or have side effects.
Observation:
- A 17-year-old male presented with an eight-month history of leishmaniasis on his left earlobe.
- The patient received a four-week course of ketoconazole treatment.
Findings:
- Ketoconazole demonstrated excellent clinical improvement in the patient's skin lesions.
- Protozoological evaluation confirmed the drug's efficacy against the leishmanial parasite.
- Ketoconazole, an imidazole derivative, acts as a broad-spectrum antimycotic agent.
Implications:
- Ketoconazole shows promise as an effective antileishmanial therapeutic agent.
- This case highlights a potential new treatment strategy for cutaneous leishmaniasis.
- Further research into ketoconazole's antileishmanial properties is warranted.